Stancic Ana 4/A
4/A · KV PHARMACEUTICAL CO /DE/ · Filed Oct 12, 2010
Insider Transaction Report
Form 4/AAmended
KV PHARMACEUTICAL CO /DE/KVA/KVB
Stancic Ana
Director
Transactions
- Award
Option to Purchase
2010-06-24+7,500→ 7,500 totalExercise: $1.14Exp: 2020-06-24→ Class A Common Stock (7,500 underlying)
Holdings
- 0
Class A Common Stock
Footnotes (2)
- [F1]The reporting person inadvertently reported the June 24, 2010 receipt of an option to purchase as a grant of unrestricted common stock on the reporting person's Form 4.
- [F2]The option vests in five euqal installments beginning on June 24, 2011.